Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Biosyent Inc V.RX

Alternate Symbol(s):  BIOYF

Healthcare
BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing... see more

Bullboard (TSXV:RX)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 Next
Post by theinvestor22on May 27, 2021 11:32am

Q1 2021 results

Nice results.  Large one time intl. sale.  Also, large initial promo expense for Tibella and Combogesic.  Do they offset?  Probably, because you have to consider that there is a ...more  
140
Post by overnouton May 27, 2021 8:25am

Q1 Financials - Presntation

https://www.biosyent.com/q1-21/#.YK-PgjZKgUs
96
Post by overnouton May 27, 2021 8:15am

Earnings Out - Great Q1

MISSISSAUGA, Ontario, May 27, 2021 (GLOBE NEWSWIRE) --  BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months ended March ...more  
110
Post by lscfaon May 03, 2021 9:43am

Accolades

https://www.globenewswire.com/news-release/2021/05/03/2221306/0/en/FeraMAX-Named-1-Recommended-Iron-Supplement-by-National-Pharmacists-and-Physicians-for-Sixth-Consecutive-Year.html
82
Comment by theinvestor22on Mar 22, 2021 9:46pm

RE:New Interview:

Thanks for posting that interview.  Much appreciated.  Lots of really useful info.
96
Discussion
Comment by lscfaon Mar 22, 2021 5:33pm

RE:Combogesic

" Combogesic sales in 4Q-20 were only the result of wholesaler stocking, however feedback from customers has been positive." - Bloom Burton
145
Discussion
Post by overnouton Mar 17, 2021 8:26am

Year End Results

BioSyent Releases Financial Results for Fourth Quarter and Full Year 2020   03/17/2021 8:00:00 AM   MISSISSAUGA, Ontario, March 17, 2021 (GLOBE NEWSWIRE) ...more  
144
Comment by lscfaon Mar 16, 2021 10:18am

RE:Combogesic

Can be ordered on-line. $15.49 for 30 pack. Now people just need to find out about it.  https://www.pharmexdirect.com/product/combogesic/  
97
Discussion
Post by overnouton Mar 16, 2021 8:17am

Combogesic

New treatment option offers a clinically proven 3.3:1 acetaminophen to ibuprofen ratio MISSISSAUGA, ON, March 16, 2021 /CNW/ -  BioSyent Inc. ("BioSyent", " ...more  
169
Discussion
Comment by theinvestor22on Mar 11, 2021 9:08am

RE:Earnings Release Scheduled

It won't be the Q4 earnings that will be of primary importance to me, although there might be some Tibella revenue plus a small amount of revenue from initial filling up of the supply chain from ...more  
147
Discussion
Post by overnouton Mar 11, 2021 8:50am

Earnings Release Scheduled

MISSISSAUGA, Ontario, March 11, 2021 (GLOBE NEWSWIRE) --  BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three ...more  
113
Discussion
Comment by overnouton Dec 17, 2020 9:26am

RE:RE:Top Gainers

My bad, 330,000 share day
114
Discussion
Comment by overnouton Dec 17, 2020 9:19am

RE:Top Gainers

It is hard to imagine volume picking up in any kind of considerble way. With a float of only 9.4M shares and the NCIB further reducing float count by 900K this ends up being a very illiquid stock ...more  
160
Discussion
Post by retiredcfon Dec 17, 2020 7:51am

Top Gainers

We need more trading volume but this is the first time I can recall them cracking this list. GLTA Symbol/ Company Price $ Change $ Volume  ...more  
173
Discussion
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities